| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 13 |
| 1 | METHOTREXATE | 9 |
| 2 | METHOTREXATE SODIUM | 9 |
| 3 | INFLIXIMAB | 8 |
| 4 | ETANERCEPT | 6 |
| 5 | OBINUTUZUMAB | 6 |
| 6 | PREDNISOLONE | 6 |
| 7 | PREDNISOLONE ORAL | 6 |
| 8 | PREDNISOLONE ORAL SOLUTION | 6 |
| 9 | ASPIRIN | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | OXICONAZOLE NITRATE | 1 | 0.0058 |
| 1 | PINDOLOL | 1 | 0.0012 |
| 2 | TAFASITAMAB-CXIX | 1 | 0.0011 |
| 3 | PIRTOBRUTINIB | 1 | 0.0010 |
| 4 | TENECTEPLASE | 1 | 0.0006 |
| 5 | EPOETIN ALFA-EPBX | 1 | 0.0004 |
| 6 | DEFLAZACORT | 1 | 0.0004 |
| 7 | FAMCICLOVIR | 1 | 0.0004 |
| 8 | OBINUTUZUMAB | 6 | 0.0004 |
| 9 | BENDAMUSTINE HCL | 5 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Thrombopoietin Receptor Agonist [EPC] | 2 | 0.0001 |
| 2 | Hedgehog Pathway Inhibitor [EPC] | 1 | 0.0001 |
| 3 | BCL-2 Inhibitor [EPC] | 4 | 0.0001 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 5 | Recombinant Human Deoxyribonuclease 1 [EPC] | 1 | 0.0001 |
| 6 | CD20-directed Cytolytic Antibody [EPC] | 16 | 0.0001 |
| 7 | Integrin Receptor Antagonist [EPC] | 4 | 0.0000 |
| 8 | Aromatase Inhibitor [EPC] | 4 | 0.0000 |
| 9 | Leukocyte Growth Factor [EPC] | 3 | 0.0000 |